Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Cancer
Published in: BMC Cancer 1/2017

Open Access 01-12-2017 | Erratum

Erratum to: Solitary plasmacytoma: population-based analysis of survival trends and effect of various treatment modalities in the USA

Authors: Nishitha Thumallapally, Ahmed Meshref, Mohammed Mousa, Terenig Terjanian

Published in: BMC Cancer | Issue 1/2017

Login to get access

Excerpt

After publication of the original article [1] the authors found the following errors had occurred:
1.
Figure titles were incorrect:
 
  • Figure 1 should be titled: Kaplan-Meier survival curve comparing sequence of RT in patients who received RT and surgery (Fig. 1)
  • Figure 2 should be titled: Kaplan-Meier survival curve comparing patients who received RT vs. no RT (Fig. 2)
  • Figure 3 should be titled: Kaplan-Meier survival curve comparing patients who received surgery vs. those that did not (Fig. 3)
2.
In Table 6, all P values should be <0.001 instead of >0.001 (Table 6)
 
Table 6
Cox proportional hazards model for prognostic factors
Variables
Hazard ratio
95% CI
P value
Lower
Upper
Age < 60 years
0.380
0.330
0.440
< 0.001
Radiation sequence with surgery
1.226
.966
1.557
.094
Radiation
0.597
0.522
0.684
< 0.001
Surgery
0.746
0.693
0.802
< 0.001
…
Literature
1.
Thumallapally, N, Meshref, A, Mousa, M and Terjanian, T. Solitary plasmacytoma: population-based analysis of survival trends and effect of various treatment modalities in the USA, BMC Cancer, 2017, 17:13, doi:10.​1186/​s12885-016-3015-5
Metadata
Title
Erratum to: Solitary plasmacytoma: population-based analysis of survival trends and effect of various treatment modalities in the USA
Authors
Nishitha Thumallapally
Ahmed Meshref
Mohammed Mousa
Terenig Terjanian
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2017
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-017-3427-x

Other articles of this Issue 1/2017

BMC Cancer 1/2017 Go to the issue

Research article

Prostate cancer-specific survival among warfarin users in the Finnish Randomized Study of Screening for Prostate Cancer

Research article

The feasibility and benefit of a brief psychosocial intervention in addition to early palliative care in patients with advanced cancer to reduce depressive symptoms: a pilot randomized controlled clinical trial

Research article

Addition of rituximab to CHOP-like chemotherapy in first line treatment of primary mediastinal B-cell lymphoma

Research article

Divergent trends in lung cancer incidence by gender, age and histological type in Estonia: a nationwide population-based study

Research article

Clinicopathological and prognostic significance of programmed death ligand-1 expression in breast cancer: a meta-analysis

Research article

Radiofrequency ablation for liver metastases in patients with gastric cancer as an alternative to hepatic resection
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits